Advanced search
Start date
Betweenand
(Reference retrieved automatically from Web of Science through information on FAPESP grant and its corresponding number as mentioned in the publication by the authors.)

Losartan reverses impaired osseointegration in spontaneously hypertensive rats

Full text
Author(s):
Mulinari-Santos, Gabriel [1, 2, 3, 4, 5] ; de Souza Batista, Fabio Roberto [4, 5] ; Kirchweger, Franziska [1, 3] ; Tangl, Stefan [1, 3] ; Gruber, Reinhard [1, 2, 6] ; Okamoto, Roberta [7]
Total Authors: 6
Affiliation:
[1] Austrian Cluster Tissue Regenerat, Vienna - Austria
[2] Med Univ Vienna, Sch Dent, Dept Oral Biol, Vienna - Austria
[3] Med Univ Vienna, Sch Dent, Dept Oral Surg, Karl Donath Lab Hard Tissue & Biomat Res, Vienna - Austria
[4] Univ Estadual Paulista, Aracatuba Dent Sch, Dept Oral Surg, Aracatuba - Brazil
[5] Univ Estadual Paulista, Aracatuba Dent Sch, Integrated Clin, Aracatuba - Brazil
[6] Univ Bern, Sch Dent Med, Dept Periodontol, Bern - Switzerland
[7] Univ Estadual Paulista, Aracatuba Dent Sch, Dept Basic Sci, Aracatuba - Brazil
Total Affiliations: 7
Document type: Journal article
Source: Clinical Oral Implants Research; v. 29, n. 11, p. 1126-1134, NOV 2018.
Web of Science Citations: 3
Abstract

Objective Hypertension is not only associated with cardiovascular diseases but also with alterations in bone quality. Hypertension therefore might be a risk factor for osseointegration. Preclinical studies suggest that losartan, an angiotensin II receptor blocker widely used to treat hypertension, has a beneficial effect in graft consolidation. Here, we determine the effect of hypertension and losartan on osseointegration. Methods Results We used spontaneously hypertensive rats (SHR) and normotensive Wistar albinus rats receiving losartan (30 mg/kg, p.o.) or left untreated. After 1 week, titanium miniscrews were inserted into the tibia. Sixty days after implantation, implant stability was evaluated by removal torque measurement considered the primary endpoint. Microcomputed tomography and histomorphometric analysis were secondary endpoints. Losartan increased the removal torque in the hypertensive SHR group to levels of the Wistar controls. While the cortical parameters of osseointegration remained unchanged, losartan increased medullary bone formation. Microcomputed tomography revealed a higher bone volume per tissue volume and trabecular thickness in the SHR rats treated with losartan. Histomorphometric analysis further showed that losartan significantly increased the thickness of newly formed bone in medullary area in hypertensive SHR rats. Losartan did not significantly alter the parameters of osseointegration in normotensive rats. Conclusions The data presented suggest that the angiotensin II receptor antagonist losartan increases the medullary parameters of osseointegration in a tibia model of spontaneously hypertensive rats. Considering the study limitations, understanding the impact of hypertension and the respective drugs on osseointegration requires further research. (AU)

FAPESP's process: 16/03245-2 - Peri-implant bone healing in the tibia of spontaneously hypertensive rats (SHR) treated with losartan: a biomechanical, molecular, microtomography, bone dynamics by fluorochromes, immunohistochemical and histological analysis
Grantee:Gabriel Mulinari dos Santos
Support type: Scholarships in Brazil - Master
FAPESP's process: 17/08081-0 - Histomorphometric analysis of peri-implant bone healing in spontaneously hipertensive rats (SHR) treated with losartan
Grantee:Gabriel Mulinari dos Santos
Support type: Scholarships abroad - Research Internship - Master's degree